Mirae Asset Global ETFs Holdings’s Capricor Therapeutics CAPR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$763K	Buy	31,779 +6,938	+28%	+$210K	﹤0.01%	1772
2026 Q1	$744K	Buy	24,841 +6,978	+39%	+$186K	﹤0.01%	1671
2025 Q4	$516K	Sell	17,863 -82	-0.5%	-$1.07K	﹤0.01%	1879
2025 Q3	$129K	Sell	17,945 -5,631	-24%	-$41.5K	﹤0.01%	2551
2025 Q2	$237K	Sell	23,576 -1,975	-8%	-$20.9K	﹤0.01%	2193
2025 Q1	$250K	Sell	25,551 -199	-0.8%	-$2.76K	﹤0.01%	2202
2024 Q4	$355K	Buy	25,750 +11,610	+82%	+$203K	﹤0.01%	2085
2024 Q3	$215K	Buy	+14,140	New	+$69.9K	﹤0.01%	2347

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CAPR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Capricor Therapeutics (CAPR) stake by 28% in Q2 2026, buying an estimated $210K and bringing the position to 31,779 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

Mirae Asset Global ETFs Holdings first reported a position in CAPR in Q3 2024 and has held it in 8 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Mirae Asset Global ETFs Holdings held 31,779 shares of Capricor Therapeutics worth $763K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 6,938 Capricor Therapeutics shares in Q2 2026, an estimated $210K.
Capricor Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1772 holding.
Mirae Asset Global ETFs Holdings first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 8 quarters since.
169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.